Analysis of thrombopoietin receptor (c-mpl) mRNA expression in de novo acute myeloid leukemia

Leukemia Research

Volumn 24, Issue 5, 2000, Pages 401-409

  Schröder, Jan K ^a   Kolkenbrock, Sara ^a   Tins, Jutta ^a   Kasimir Bauer, Sabine ^a   Seeber, Siegfried ^a   Schütte, Jochen ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

Author keywords

Acute myeloid leukemia; c mpl; Prognostic factors; Thrombopoietin receptor

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOKINE RECEPTOR; IDARUBICIN; MESSENGER RNA; THROMBOPOIETIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; KARYOTYPE; LEUKEMIA REMISSION; MYELODYSPLASIA; PRIORITY JOURNAL; PROGNOSIS;

ACUTE DISEASE; ADULT; AGED; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, MYELOID; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RECEPTORS, CYTOKINE; RECEPTORS, THROMBOPOIETIN; RNA, MESSENGER; SURVIVAL ANALYSIS; THROMBOPOIETIN; TUMOR MARKERS, BIOLOGICAL;

EID: 0343293998     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(99)00201-5     Document Type: Article

References (45)

1. Budel L.M., Touw I.P., Delwel R., Clark S.C., Lowenberg B. Interleukin-3 and granulocyte-monocyte colony-stimulating factor receptors on human acute myelocytic leukemia cells and relationship to the proliferative response. Blood. 74:1989;565.
2. Park L.S., Waldron P.E., Friend D., Sassenfeld H.M., Price V., Anderson D., Cosman D., Andrews R.G., Bernstein I.D., Urdal D.L. Interleukin-3, GM-CSF, and G-CSF receptor expression on cell lines and primary leukemia cells: receptor heterogeneity and relationship to growth factor responsiveness. Blood. 74:1989;56.
3. Begley C.G., Metcalf D., Nicola N.A. Primary human myeloid leukemia cells: comparative responsiveness to proliferative stimulation by GM-CSF or G-CSF and membrane expression of CSF receptors. Leukemia. 1:1987;1.
4. Dubreuil P., Torres H., Courcoul M.A., Birg F., Mannoni P. c-fms expression is a molecular marker of human acute myeloid leukemias. Blood. 72:1988;1081.
5. Ikeda H., Kanakura Y., Tamaki T., Kuriu A., Kitayama H., Ishikawa J., Kanayama Y., Yonezawa T., Tarui S., Griffin J.D. Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells. Blood. 78:1991;2962.
6. Lerner N.B., Nocka K.H., Cole S.R., Qiu F., Strife A., Ashman L.K., Besmer P. Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood. 77:1991;1876.
7. Broudy V.C., Smith F.O., Lin N., Zsebo K.M., Egrie J., Bernstein I.D. Blasts from patients with acute myelogenous leukemia express functional receptors for stem cell factor. Blood. 80:1992;60.
8. Depper J.M., Leonard W.J., Krönke M., Waldmann T.A., Greene W.C. Augmented T cell growth factor receptor expression in HTLV-1 infected human leukemic T cells. J. Immunol. 133:1984;1691.
9. Rambaldi A., Wakamiya N., Vellenga E., Horiguchin J., Warren M.K., Kufe D., Griffin J.D. Expression of the macrophage colony stimulating factor and c-FMS genes in human acute myeloblastic leukemia cells. J. Clin. Invest. 81:1988;1030.
10. Mitjavila M.T., le Couedic J.P., Casadevall N., Navarro S., Vileval J.L., Dubart A., Vainchenker W. Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemic cells in vitro. J. Clin. Invest. 88:1991;789.
11. Eaves A.C., Eaves C.J. Erythropoiesis in culture. Clin. Haematol. 13:1984;371.
12. Prchal J.F., Axelrad A.A. Bone marrow responses in polycythemia vera. New Engl. J. Med. 290:1974;1382.
13. Vigon I., Mornon J.P., Cocault L., Mitjavila M.T., Tambourin P., Gisselbrecht S., Souyri M. Molecular cloning and characterization of h-mpl, the human homolog of the v-mpl oncogene: Identification of a new member of the hematopoietic growth factor receptor superfamily. Proc. Natl. Acad. Sci. USA. 898:1992;5640.
14. Bartley T.D., Bogenberger J., Hunt P., Li Y.S., Lu H.S., Martin F., Chang M.S., Samal B., Nichol J.L., Swift S. et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell. 77:1994;1117.
15. de Sauvage F.J., Hass P.E., Spencer S.D., Malloy B.E., Gurney A.L., Spencer S.A., Darbonne W.C., Henzel W.J., Wong S.C., Kuang W.J. et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature. 369:1994;533.
16. Lok S., Kaushansky K., Holly R.D., Kuijper J.L., Lofton-Day C.E., Oort P.J., Grant F.J., Heipel M.D., Burkhead S.K., Kramer J.M. et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature. 369:1994;565.
17. Kaushansky K., Lok S., Holly R.D., Broudy V.C., Lin N., Bailey M.C., Forstrom J.W., Buddle M.M., Oort P.J., Hagen F.S. et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature. 369:1994;568.
18. Wendling F., Maraskovsky E., Debili N., Florindo C., Teepe M., Titeux M., Methia N., Breton-Gorius J., Cosman D., Vainchenker W. c-Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature. 369:1994;571.
19. Souyri M., Vigon I., Penciolelli J.F., Heard J.M., Tambourin P., Wendling F. A putative truncated cytokine receptor gene transduced by the myeloablative leukemia virus immortalizes hematopoietic progenitors. Cell. 63:1990;1137.
20. Wendling F., Vigon I., Souyri M., Tambourin P. Myeloid progenitor cells transformed by the myeloproliferative leukemia virus proliferate and differentiate in vitro without the addition of growth factors. Leukemia. 3:1989;475.
21. Wendling F., Penciolelli J.F., Charon M., Tambourin P. Factor-independent erythropoietic progenitov cells in leukemia induced by the myeloproliferative leukemia virus. Blood. 73:1989;1161.
22. Methia N., Louache F., Vainchenker W., Wendling F. Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood. 82:1993;1395.
23. Zeigler F.C., de Sauvage F., Widmer H.R., Keller G.A., Donahue C., Schreiber R.D., Malloy B., Hass P., Eaton D., Matthews W. In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood. 84:1994;4045.
24. Wetzler M., Baer M.R., Bernstein S.H., Blumenson L., Stewart C., Barcos M., Mrozek K., Block A.W., Herzig G.P., Bloomfield C.D. Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapy. J. Clin. Oncol. 15:1997;2262.
25. Vigon I., Dreyfus F., Melle J., Viguié F., Ribrag V., Cocault L., Souyri M., Gisselbrecht S. Expression of the c-mpl proto-oncogene in human hematologic malignancies. Blood. 82:1993;877.
26. Bouscary D., Preudhomme C., Ribrag V., Melle J., Viguié F., Picard F., Guesnu M., Fenaux P., Gisselbrecht S., Dreyfus F. Prognostic value of c-mpl expression in myelodysplastic syndromes. Leukemia. 9:1995;783.
27. Cheson B.D., Cassileth P.A., Head D.R., Schiffer C.A., Bennett J.M., Bloomfield C.D., Brunning R., Gale R.P., Grever M.R., Keating M.J., Sawitsky A., Stass S., Weinstein H., Woods W.G. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J. Clin. Oncol. 8:1990;813.
28. Grimwade D., Walker H., Oliver F., Wheatley K., Harrison C., Harrison G., Rees J., Hann I., Stevens R., Burnett A., Goldstone A. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood. 92:1998;2322.
29. Schröder J.K., Kirch C., Flasshove M., Kalweit H., Seidelmann M., Hilger R., Seeber S., Schütte J. Constitutive overexpression of the cytidine deaminase gene confers resistance to cytosine arabinoside in vitro. Leukemia. 10:1996;1919.
30. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156.
31. Schröder J., Esteban M., Müller M.R., Kasimir-Bauer S., Bamberger U., Heckel A., Seeber S., Scheulen M.E. Modulation of multidrug resistance by BIBW22BS in blasts of de novo or relapsed or persistent acute myeloid leukemia ex vivo. J. Cancer Res. Clin. Oncol. 122:1996;307.
32. Mayer R.J., Davis R.B., Schiffer C.A., Berg D.T., Powell B.L., Schulman P., Omura G.A., Moore J.O., McIntyre O.R., Frei E. 3rd. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. New Engl. J. Med. 331:1994;896.
33. Raspadori D., Lauria F., Ventura M.A., Rondelli D., Visani G., de Vivo A., Tura S. Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: analysis of 141 cases. Leuk. Res. 21:1997;603.
34. Kaushansky K., Lin N., Grossmann A., Humes J., Sprugel K.H., Broudy V.C. Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice. Exp. Hematol. 24:1996;265.
35. Farese A.M., Hunt P., Grab L.B., MacVittie T.J. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation induced marrow aplasia. J. Clin. Invest. 97:1996;2145.
36. Broudy V.C., Lin N.L., Fox N., Taga T., Saito M., Kaushansky K. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit. Blood. 88:1996;2026.
37. Solar GP, Kerr WG, Zeigler FC, Hess D, Donahue C, de Sauvage FJ, Eaton DL. Role of c-mpl in early hematopoiesis. Blood 1998;92:4.
38. Young J.C., Bruno E., Luens K.M., Wu S., Backer M., Murray L.J. Thrombopoietin stimulates megakaryocytopoiesis, myelopoiesis, and expansion of CD34+ progenitor cells from single CD34+Thy-1+Lin- primitive progenitor cells. Blood. 88:1996;1619.
39. -) human bone marrow progenitor cells. J. Immunol. 158:1997;5169.
40. Matsumura I., Ikeda H., Kanakura Y. The effects of thrombopoietin on the growth of acute myeloblastic leukemia cells. Leuk. Lymphoma. 23:1996;533.
41. Piacibello W., Sanavio F., Brizzi M.F., Garetto L., Severino A., Aronica M.G., Dragonetti G., Aglietta M., Pegoraro L. Megakaryocyte growth and development factor (MGDF)-induced acute leukemia cell proliferation and clonal growth is associated with functional c-mpl. Leukemia. 11:1997;531.
42. Takeshita A., Shinjo K., Izumi M., Ling P., Nakamura S., Naito K., Ohnishi K., Ohno R. Quantitative expression of thrombopoietin receptor on leukaemia cells from patients with acute myeloid leukaemia and acute lymphoblastic leukaemia. Br. J. Haematol. 100:1998;283.
43. Quentmeier H., Zaborski M., Graf G., Ludwig W.D., Drexler H.G. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells. Leukemia. 10:1996;297.
44. Rowe J.M., Liesveld J.L. Hematopoietic growth factors in acute leukemia. Leukemia. 11:1997;328.
45. Albitar M., Manshouri T., Kantarjian H., Keating M., Estrov Z., Faber J., Freireich E.J., Pierce S., Estey E. Correlation between lower c-mpl protein expression and favorable cytogenetic groups in acute myeloid leukemia. Leuk. Res. 23:1999;63.